RESEARCH: COVID-19
FOLDING PROJECT #16451 PROFILE

This project explores the SARS-CoV-2 virus's NSP10 protein. Researchers are using computer simulations to study how each part of NSP10 works. NSP10 activates other viral proteins needed for replication, making it a potential drug target. By understanding how NSP10 works, scientists hope to find new ways to stop the COVID-19 virus.

Note: This TLDR is a simplication and may not be 100% accurate.

This project is studying the NSP10 (Non-structural-protein-10) of SARS-CoV-2! In this project we are analyzing the role of _every_ single residue in NSP10 using a computational mutagenesis approach.

Each RUN in this project is simulating a unique mutant of NSP10, which we will compare to one another to identify critical residues of importance for NSP10 function.

NSP10 is an "activator" protein for critical viral function.

Two other proteins, NSP14, and NSP16 are important enzymes for viral function, but they both require NSP10 to bind them and "activate" them.

Without NSP10, these two enzymes would not function which would inhibit the virus from being able to replicate and transmit the infection COVID19.

This makes NSP10 an interesting potential biological target, as blocking its role as an activator could provide a therapeutic opportunity. However, it only participates in protein-protein interactions and does not have any obvious "pockets" or grooves amenable to targeting by drug design methods.

We are simulating NSP10 to identify potential druggable sites that have not been previously observed using experimental studies.

From a basic research standpoint, it will also be useful to understand how NSP10 actually "activates" its targets, as the mechanism of activation remains unknown.

---

NSP10

Non-structural protein 10

NSP10 is a viral protein found in SARS-CoV-2. It acts as an activator for other viral proteins, NSP14 and NSP16, which are essential for viral replication and transmission. Blocking NSP10's function could be a potential therapeutic target to inhibit the virus.

---

SARS-CoV-2

Severe Acute Respiratory Syndrome Coronavirus 2

SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. It is a type of coronavirus that primarily affects the respiratory system.

---

COVID-19

Coronavirus Disease 2019

COVID-19 is the infectious disease caused by the SARS-CoV-2 virus. It can cause a range of symptoms, from mild to severe, and can lead to complications such as pneumonia.

---

Mutagenesis

The process of introducing changes to the genetic material (DNA) of an organism.

Mutagenesis is a scientific technique used to create mutations in DNA. Researchers use mutagenesis to study the function of genes and to develop new drugs and therapies.

---

Protein-protein interactions

The physical association between two or more protein molecules.

Protein-protein interactions are essential for many biological processes. Proteins often work together to carry out specific functions, and these interactions can be regulated by various factors.

---

Drug design

The process of designing and developing new drugs.

Drug design is a complex process that involves identifying potential drug targets, screening for compounds that interact with these targets, and optimizing the properties of lead compounds.

---

Therapeutic

Relating to the treatment or prevention of disease.

Therapeutic refers to any treatment or intervention aimed at preventing or curing a disease. This includes medications, surgery, and lifestyle changes.